Differences between mean levels of P-R and proportions with extrasystoles differ significantly at P <0 05.
Discussion An aspect of this study which requires careful consideration is the sensitivity of the various comparisons made. This can be judged from the sizes of the standard errors (S.E.) shown in Tables I and II . These indicate that for each of the variables a difference which is smaller than that likely to be clinically important would have been detected as statistically significant at conventional levels twice the S.E. of the difference between the two means). Thu* or blood pressure differences in means of more than 3-6 mm systolic or 2-3 mm diastolic, or a difference greater than 6-5 mg of cholesterol, would be statistically significant at P < 0 05. All these differences, and those for the other variables, are acceptably small. The few differences which have been detected at P < 0-05 are difficult to interpret. There is a significant difference in mean age (2-1 years) but this is very small and unlikely to be important in the.,overall comparisons presented. In any case the data were analysed within three age groups separately and the conclusions which follow are based on this more detailed examination. The significant difference in mean P-R duration is of interest as it is consistent within the three age groups, but its clinical importance is unknown. The increased proportion of men with extrasystoles of ventricular origin in hard water areas is statistically significant but is not consistent in direction within the three age groups examined. A measurement based on a short E.C.G. run is unlikely to be reliable either for an individual or for a group, but, nevertheless, the presence of ventricular extrasystoles in a routine E.C.G. has been shown to indicate an increased mortality risk (Chiang, Perlman, Ostrander, and Epstein, 1969) . The higher prevalence of angina in the hard water area, though not significant, is also of interest, as it is inconsistent with a lower mortality in these areas. However, hardness of water appears to be relevant to the process of infarction rather than to the development of arteriosclerosis (Crawford and Crawford, 1967) . The Q-T interval in the two groups is identical, even when examined as a regression on R-R. This is of interest, as a prolongation of this interval is associated with sudden death (James, 1969) . It is perhaps more important, however, to stress the absence in these data of differences in most variables which are statistically or clinically important. While they cannot rule out, with absolute certainty, any of the possible mechanisms by which water affects mortality, they do indicate areas into which future investigations may most profitably be directed.
Introduction
The efficacy of any form of treatment of osteosarcoma has always been low, and the rarity of the disease has hindered the collection of sufficient information on which to base an evaluation of the respective merits of surgery, radiotherapy, and a combination of the two forms of treatment. The M.R.C. Of the 201 patients with osteosarcoma four were givcn palliative treatment only and three none at all; two more had to be excluded from any comparison of the three main types of treatment because only local excision had been performed. There thus remained 192 patients in all for further consideration.
With this procedure, designed to include all cases from each centre, there was no bias in the selection of the material. The clinical details were often incomplete. Progress was not always reported, and failure to record a patient's destination on discharge made it difficult to trace him as he was transferred from one hospital to another-perhaps from a small hospital where he was first examined to a larger unit for biopsy and then to a radiotherapy centre. It was also often impossible to discover why a particular course of action had been taken: the reasons for deciding on, say, amputation after radiotherapy or for the length of the interval between these two procedures had not been recorded. It seemed that the choice depended mainly on the policy of the centre concerned, all patients referred to it tending to be given similar treatment.
Findings
Of the 192 patients 62% were male and 38' female, a ratio of 1 6 to 1 (Table I ). In 125 patients the site of the sarcoma was the femur (the lower end in 111 cases) and in 67 the tibia (the upper end in 56). Thus 83%o of tumours occurred around the knee joint. The distribution in relation to age followed the typical pattern, except that there were fewer older patients than might be expected with osteosarcoma in association with Paget's disease. Nevertheless, as expected, this combination was found in most of the small group of 11 patients aged 60 years and over, nine of whom had Paget's disease. The average duration of symptoms before treatment began was three months; among those who survived, it was four months. Pain alone was the presenting symptom in 63%,' of patients, swelling alone in 16%, and both simultaneously in 200°; thus pain was a presenting symptom in 83% altogether. Only 12%, of patients gave a history of injury, and none of fractures. Sun-ray spicules, said to be a characteristic radiographic feature, were present in only 16% of cases.
Eighty patients (42%') were treated by a combination of radiotherapy and amputation, 61 (320o) by amputation alone, and 51 (27%) by radiotherapy. In the first group, two were irradiated before and after amputation and the rest only before amputation. The interval between completion of irradiation and amputation varied greatly. There were considerable variations in the duration and dosage of radiotherapy. 365 were somewhat better if a tumour was vcry small, particularly in patients treated by amputation alone. There was no correlation between tumour size and length of history. Pulmonary metastases developed within 10 months, on average, of starting treatment, and the average period between the discovery of pulmonary metastases and death was six months. Resection of a solitary metastasis was carried out in only three patients; one died six months after lobectomy, at which hilar glands were found to be involved, and the other two were alive four and a half and seven years afterwards with no evidence of recurrence.
SURVIVAL
Lymph node metastases were found in 31O of those who died; but necropsies were performed in barely lO00 of the cases in this series, and the records seldom indicated whether a search was made for such metastases either at necropsy or at amputation. Nunumber trcatcd.
Percentage surviving.
surviving of those treated by radiotherapy alone (11 8"O) was only half that for patients treated by amputation alone (23"') or by both methods in combination (27 50o). The contrast was even greater for those under 20 years of age, but little difference emerged in older paticnts. Table IV and Fig. 3 , which are analogous to Table II and Fig. 1 , show the proportions in each treatment group surviving to specified intervals from the start of treatment. Though the radiotherapy group showed a consistently poorer survival rate than the amputation group and the group treated by both methods, the differences were small and not significant at sixmonth and 12-month intervals; only from 24 months onwards did the proportion surviving among those treated by radiotherapy alone appear significantly lower. Median survival periods were 12-4 months for radiotherapy, 16-5 months for amputation, and 18-9 months for both methods.
The percentage of survivors according to the interval between radiotherapy and amputation among the 80 patients treated by both methods is given in Table V ; it will be seen that where (Table II and Fig. 1 ). For this Paget's sarcoma was chiefly to blame. In the other small group of 12 patients with parosteal growths the prognosis was much better (Fig. 2) that of the group treated by amputation or of the group treated by a combination of radiotherapy and amputation (Table III and Fig. 3) ; among the much smaller number of older patients there were no significant differences in survival between the treatment groups. Despite the apparent failure of radiotherapy alone, it is impossible to draw any conclusion about the relative merits of these treatments without knowing why the particular form of treatment was chosen for each patient, and this information was very rarely available in the case notes. The demonstration that survival rate was better when the interval between radiotherapy and amputation was longer (Table V) illustrates the difficulty; one explanation of'this-finding could be that the patients who had the operation six or more months after radiotherapy had already demonstrated their ability to survive a period which had seen the death of the more serious casesthat is, they were a selected group of patients with a better prognosis irrespective of treatment. Furthermore, we do not know how many patients were intended to have combined treatment, but were given radiotherapy alone because pulmonary metastases had developed early before amputation could be performed; neither do we know how often it was hoped that radiotherapy alone would suffice, but the failure of response or local recurrence necessitated surgery in addition. A comparison can be made between all those patients treated by radiotherapy (whether or not there was a subesquent amputation) and those treated by amputation alone. This is shown in 
Introduction
The reticuloendothelial system is important in the natural resistance of cancer patients to the spread of their tumours (Green et al., 1967) . Phagocytic activity in particular has been found to reflect this resistance (Magarey and Baum, 1970) . But this activity is depressed by ionizing radiation or cytotoxic drugs used in the treatment of patients with cancer (Magarey and Baum, 1970) . In animals the spread of tumours is increased by agents which depress reticuloendothelial phagocytic activity (Kondo and Moor, 1961; Reiner and Southam, 1966; Dao and Yogo, 1967; Rosenau and Moon, 1967) . Conversely, agents which stimulate reticuloendothelial phagocytic activity reduce the spread of these tumours (Bradner and Clarke, 1959; Old et al., 1961; Yamaguchi et al., 1965; Halpern et al., 1966; Woodruff and Boak, 1966) . Such reticuloendothelial stimulants potentiate the antitumour effects of cytotoxic compounds (Sokoloff et al., 1961; Martin et al., 1964) . So far, there have been few serious attempts to stimulate reticuloendothelial activity in humans with cancer, though Mathe (1969) claimed some success with B.C.G. in patients with leukaemia. Oestrogens are potent stimulants of reticuloendothelial phagocytic activity in laboratory animals (Nicol, 1935; Biozzi et al., 1957; Nicol et al., 1964) . They. like other reticuloendotheial stimulants, give some protection against the toxic effects (Baum, 1967; Field et al., 1967) . Oestrogens have been used for years in the treatment of patients with breast or prostatic cancer, but their mode of action is not fully understood. Nicol et al. (1952) provided histological evidence that macrophage activity may be involved in the response of prostatic cancer to oestrogens, but there have been few experimental studies of the effects of oestrogen on the host response to tumour. There have been no such studies i man, though oestrogens are less toxic than the reticuloendothelial stimulants which have so far been considered for use in patients with cancer.
The following investigations were undertaken to study the effects of several oestrogens on the reticuloendothelial phagocytic activity in patients with cancer and in patients without malignant disease and, in addition, the effect of combining stilboestrol with radiotherapy in the treatment of patients with cancer.
Patients and Methods Sixty-three patients volunteered for this study (Table I) . Fifteen who had malignant disease and 33 who had no malignant disease, all of whom were in good general health, were given oestrogen. Another seven patients received stilboestrol while undergoing radiotherapy. These patients received no other specific treatment during the investigation except promethazine or perphenazine to prevent the nausea sometimes produced by oestrogen. The other eight patients without malignant disease acted as controls and took promethazine or perphenazine but no oestrogen. The results obtained in the patients undergoing radiotherapy have been compared with those obtained in 22 patients receiving similar radiotherapy without stilboestrol (Magarey and Baum, 1970) .
The oestrogens were taken orally. Stilboestrol was taken in three dose ranges (1 mg three times daily, 5-10 mg three times daily, or 25 mg four times daily). Ethinyloestradiol was taken in two dosages (01 or 1 mg three times daily). Oestriol was 
